ATI RN
Hematology Exam Questions Questions
Question 1 of 5
A 2-year- old boy presented with recurrent skin and respiratory tract infections since early infancy, he had abnormally eczematous skin of the upper and lower limbs. His initial tests showed normal liver and renal functions with CBC showing low platelets count. He has similarly affected male cousin. Of the following, the MOST likely diagnosis is
Correct Answer: B
Rationale: Wiskott-Aldrich syndrome (B) matches infections, eczema, thrombocytopenia, and X-linked family history.
Question 2 of 5
Which of the following results correctly fits the expected transfusion outcome?
Correct Answer: C
Rationale: Cryoprecipitate (C) raises fibrinogen by 50-100 mg/dl; PRBC raises Hb by 1 gm/dl, platelets by 20-40,000.
Question 3 of 5
A 28-year-old black man with sickle cell disease presents to the emergency department with abdominal pain, chest pain, and shortness of breath. His dyspnea evolved over 36 hours after a visit with his niece and nephew. His history is significant for approximately 2 emergency department visits or hospital admissions per year for painful crises. Three years ago, he spent 4 weeks in the hospital after an episode of acute chest syndrome. He has been taking hydroxyurea but only intermittently because of financial concerns. His pulse is 116 beats per minute and regular, his blood pressure is 138/76 mm Hg, his respiratory rate is 18 breaths per minute, and his temperature is 38.3°C. Pulse oximetry shows 91% oxygen saturation with room air and 93% with 4 L of oxygen by nasal cannula. His lungs have scattered inspiratory crackles in the right midlung field. His spleen is not palpable. The remainder of the physical examination findings are normal. Diagnostic testing results are shown in Table 9.Q4. A chest radiograph shows a right middle and upper lobe air space infiltrate. The patient is given supplemental oxygen, adequate pain control, and intravenous antibiotics. Which of the following should you now order?
Correct Answer: B
Rationale: Acute chest syndrome in sickle cell disease (fever, hypoxia, infiltrate) requires urgent erythrocyte exchange transfusion to reduce hemoglobin S below 30%-35%, improving oxygenation. Hydroxyurea (A) prevents crises, not acute treatment. Plasma exchange (C) is for other conditions. Anticoagulation (D) awaits embolism confirmation. Aggressive fluids (E) risk pulmonary edema.
Question 4 of 5
A 45-year-old man presents with deep vein thrombosis of the right femoral vein. Three months ago, he received a diagnosis of systemic lupus erythematosus (SLE). In addition to confirming SLE, laboratory testing also documented the presence of a lupus anticoagulant (LAC). There is no family history of venous thrombosis. Current medications include hydroxychloroquine. Laboratory testing shows normal results for a complete blood cell count and for tests of liver and kidney function. Special coagulation testing confirms the persistence of an LAC. What is the most reasonable duration of warfarin anticoagulation for this patient?
Correct Answer: D
Rationale: Persistent LAC and DVT in SLE meet antiphospholipid syndrome criteria, conferring high recurrence risk, necessitating long-term warfarin with periodic safety reassessment. Shorter durations (A, C, E) or 1 year (B) are inadequate.
Question 5 of 5
At her annual physical examination, an asymptomatic 68-year-old woman has lymphocytosis (32 × 10^9/L) with a normal hemoglobin level and platelet count. On examination, she has 1-cm lymphadenopathy in the cervical region and no palpable liver or spleen enlargement. A peripheral blood smear shows identically appearing mature lymphocytes with smudge cells. Flow cytometry of the peripheral blood lymphocytes shows a monoclonal B population with dim expression of λ light chain and CD20 that is positive for expression of CD5, CD19, and CD23. Which of the following is the best next step in her management?
Correct Answer: D
Rationale: Chronic lymphocytic leukemia (CLL) with lymphocytosis >5 × 10^9/L, smudge cells, and CD5/CD23 positivity in an asymptomatic patient with early-stage disease warrants active monitoring, not immediate treatment (A-D), per standard practice.